or
Bookmark and Share
1,2-Dimethyl-3 or 5-piperazinyl-pyrazolium salts
   
Document Number
US Patent 4032526
Issued Date
June 28, 1977
Link
Inventors
Map
Abstract
There are provided certain novel 1,2-dimethyl pyrazolium compounds having nitrogen containing substituents in the 3 or 5 position, and to both a method for controlling plant pathogenic fungi with said compounds and a method for protecting plants from an attack by fungi by applying to the foliage of plants a fungicidally effective amount of said compound.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
3
Comments:
no comments yet
Owner
Published
June 28, 1977
Application Number
05/692,069
Filed
June 2, 1976
US Classification
544/371  
Int'l Classification
C07D   231/16   (20060101)   C07D   231/38   (20060101)   C07D   231/00   (20060101)  
Attorney/Law Firm
Parent Case
This application is a divisional of our copending application, Ser. No. 619,093, filed on Oct. 2, 1975, now U.S. Pat. No. 3,988,348 which issued on Oct. 26, 1976 which in turn is a divisional of our application, Ser. No. 558,610, filed on Mar. 14, 1975, now U.S. Pat. No. 3,941,881, issued on Mar. 2, 1976.
USPTO Field of Search
260/268H  
Related Patents
4772604 - Phenyl-substituted (N-piperazinyl) methylazoles for treating affections in the central nervous system - Owned by Duphar International Research B.V. (Weesp,NL)

The invention relates to new aryl-substituted (N-piperidinyl)methyl- and (N-piperazinyl)methylazoles having interesting pharmacological, notably antipsychotic, properties. The compounds may be prepared in a manner known for the synthesis of analogous compounds and be processed to compositions according to known methods.

6774127 - Pyrazole and pyrazoline substituted compounds - Owned by SmithKline Beecham Corporation (Philadelphia, PA)

Novel pyridyl and pyrimidinyl substituted pyrazole and pyrazoline compounds and compositions for use in therapy.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us